Bordet Scientific Publications

Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.

Licata L, Mariani M, Viale G, Dent R, Tolaney SM, Schmid P, Hamilton E, Sotiriou C, Pusztai L, Bianchini G

Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

Engelhardt EG, Binuya MAE, Pharoah PDP, Poncet C, Rutgers EJT, Piccart M, Cardoso F, van 't Veer LJ, Steyerberg EW, Linn SC, Schmidt MK

Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.

Atypical Rapid Onset of Olmesartan-Induced Enteropathy with Recurrence After Rechallenging.

Bekkai L, Ibn Majah A, Verset L, Jacobs L, Danneel C, Elkilic O, Collart F, Nortier J, Taghavi M

Atypical Rapid Onset of Olmesartan-Induced Enteropathy with Recurrence After Rechallenging.

Human papillomavirus infection is a favorable prognostic factor for patients with stage I-IVA esophageal squamous cell carcinoma but not adenocarcinoma.

Reynders C, Bruyere D, Roncarati P, Geuzaine R, Koopmansch B, Gofflot S, Monnien F, Craciun L, Piazzon N, Hendrick E, Poulain F, Lerho T, Miceli S, Pilard C, Ancion M, Luyckx M, Renard M, Lambert F, Gheit T, Molimard C, Bibeau F, Larsimont D, Fasquelle F, de Leval L, Delvenne P, Kervarrec T, Hubert P, Peulen O, Herfs M

Human papillomavirus infection is a favorable prognostic factor for patients with stage I-IVA esophageal squamous cell carcinoma but not adenocarcinoma.

Atrial fibrillation ablation: Is the Ice Age definitively over?

Awada A, de Asmundis C, Chierchia GB

Atrial fibrillation ablation: Is the Ice Age definitively over?

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers.

Perachino M, Blondeaux E, Delucchi V, Bernstein Molho R, Frank S, Paluch-Shimon S, Linn S, Di Meglio A, Peccatori F, Moore HCF, Parokonnaya A, Renaud T, Rodriguez Wallberg KA, Partridge AH, Pogoda K, Ferrari A, Wildiers H, Toss A, Rousset-Jablonski C, Kim HJ, Varela M, Cordoba O, Tanase Damian C, Marhold M, Fabi A, Graff SL, Rodriguez-Hernandez A, Okano M, Duchnowska R, Luna Pais H, Di Rocco R, Azim HA, Mariamidze E, Kourie HR, Arecco L, Carrasco E, Agostinetto E, Balmana J, Saura C, Lambertini M

Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers.

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

Devos T, Deeren D, Theunissen K, Selleslag D, Bailly B, Havelange V, Lewalle P, Meers S, Benghiat FS, Gadisseur A, Granacher N, Vanstraelen G, Vellemans H, Becker A, Janssen M, Vrelust I, Lejeune M, Van de Velde A, Triffet A, Beck M, Sebti H, Mazure D

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.

Are We Ready to Escalate Radiation Doses For Limited-Stage SCLC?

Van Houtte P, Moretti L

Are We Ready to Escalate Radiation Doses For Limited-Stage SCLC?

Van Houtte P, Moretti L

Are We Ready to Escalate Radiation Doses For Limited-Stage SCLC?

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Bordet Scientific Publications